AlphaQuest’s Nutex Health NUTX Stock Holding History

AlphaQuest’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,766	Closed	-$291K	–	1378
2025 Q4	$291K	Sell	1,766 -877	-33%	-$116K	0.02%	1228
2025 Q3	$273K	Buy	2,643 +1,054	+66%	+$103K	0.02%	1223
2025 Q2	$198K	Buy	+1,589	New	+$205K	0.02%	1138

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

AlphaQuest's NUTX Position: Q1 2026 in Review

AlphaQuest sold out of Nutex Health (NUTX) in Q1 2026, closing a stake of 1,766 shares — an estimated $291K sold.

AlphaQuest first reported a position in NUTX in Q2 2025 and held it in 3 quarters. The position peaked at $291K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

AlphaQuest reported no remaining Nutex Health position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 1,766 Nutex Health shares in Q1 2026, an estimated $291K.
AlphaQuest first reported a position in Nutex Health in Q2 2025 and held it in 3 quarters.
AlphaQuest's Nutex Health position peaked at $291K in Q4 2025.
129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.